StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
15
Publishing Date
2022 - 03 - 16
1
2022 - 01 - 12
1
2022 - 01 - 05
1
2021 - 11 - 22
1
2021 - 10 - 20
1
2021 - 10 - 13
1
2021 - 08 - 17
1
2021 - 08 - 03
1
2021 - 07 - 22
1
2021 - 07 - 13
1
2021 - 07 - 07
1
2021 - 06 - 02
1
2021 - 05 - 12
1
2021 - 04 - 28
1
2021 - 04 - 13
1
Sector
Health technology
15
Tags
100
2
Agreement
1
Alliances
1
Announces collaboration
1
Application
1
Approval
1
Biotech
23
Biotech-beach
2
Bone
1
Breast cancer
1
Cancer
22
Cell
1
Ces
1
Clinical-trials-phase-ii
2
Collaboration
6
Conference
5
Direct
2
Doxorubicin
3
Drug
4
Enroll
3
Europe
1
Events
1
First
1
Group
2
Growth
1
Immunotherapy
4
Institute
2
Iot
21
Lb-100
14
License
1
Life science
1
Lung cancer
3
Modest toxicity
1
N/a
38
Nasdaq
3
Netherlands
5
Offering
7
Patent
2
People
1
Pharmaceutical
2
Phase 1
1
Phase 1b
2
Phase 2b
3
Plus
1
Pons
1
Potential
1
Pre-clinical
5
Preclinical
4
Publication
1
Research
4
Response
1
Results
2
Reveal
1
Soft tissue
1
Stimulates the signals
1
Technology
15
Therapy
3
Treatment
4
Trial
8
Update
2
Entities
17 education & technology group inc - adr
33
Abb ltd
28
Abbott laboratories
34
Accenture plc
41
Align technology, inc.
35
Alphabet inc.
32
Apple inc.
51
Arrival
86
Ase technology holding co., ltd.
54
Becton, dickinson and company
29
Broadcom inc.
25
Carpenter technology corporation
46
Centurylink, inc. d/b/a lumen technologies, inc.
33
Danaher corporation
33
Dell technologies inc.
27
Dxc technology company
27
Eli lilly and company
27
Ericsson
63
Exela technologies, inc.
28
Express, inc.
22
Ford motor company
23
General electric company
25
Genetic technologies ltd
22
Glaxosmithkline plc
23
Gorilla technology group inc.
37
Gsi technology, inc.
27
Honeywell international inc.
45
Infineon technologies ag
24
Intel corporation
44
International business machines corporation
27
International game technology
48
Johnson & johnson
45
Kbr, inc.
29
Koninklijke philips n.v.
26
Kulr technology group inc
46
Lockheed martin corporation
23
Microchip technology incorporated
65
Micron technology, inc.
26
Microsoft corporation
47
Mind technology, inc.
41
Morgan stanley
87
Naas technology inc - adr
53
Nec corp
24
New oriental education & technology group, inc.
24
Oracle corporation
27
Orange
86
Rackspace technology, inc.
194
Roper technologies, inc.
25
Sanofi
68
Sap se
39
Senmiao technology limited
33
Shoulderup technology acquisition corp.
24
Sony group corp
26
Sunlands technology group
33
Thermo fisher scientific inc
60
Trimble inc.
22
Viomi technology co., ltd
29
Vir biotechnology, inc.
27
Vishay intertechnology, inc.
43
Wisekey international holding ag
26
Symbols
LIXT
15
Exchanges
Nasdaq
15
Crawled Date
2022 - 03 - 16
1
2022 - 01 - 12
1
2022 - 01 - 05
1
2021 - 11 - 22
1
2021 - 10 - 20
1
2021 - 10 - 13
1
2021 - 08 - 17
1
2021 - 08 - 03
1
2021 - 07 - 22
1
2021 - 07 - 13
1
2021 - 07 - 07
1
2021 - 06 - 02
1
2021 - 05 - 12
1
2021 - 04 - 28
1
2021 - 04 - 13
1
Crawled Time
13:00
1
14:00
12
14:30
2
Source
www.biospace.com
4
www.globenewswire.com
11
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Technology
entities :
Lixte biotechnology holdings inc.
save search
LIXTE Biotechnology Holdings, Inc. to Present at MedInvest Pharmaceutical and Biotechnology Investor Conference
Published:
2022-03-16
(Crawled : 13:00)
- biospace.com/
LIXT
|
$3.5
4.68%
13K
|
Health Technology
|
218.18%
|
O:
20.0%
H:
0.0%
C:
-8.33%
technology
conference
biotech
iot
Lixte Biotechnology Announces Filing of First Patent Application Resulting from Collaboration with the Netherlands Cancer Institute and the Oncode Institute to Identify the Most Promising Drug Combinations for Lead Clinical Compound, LB-100
Published:
2022-01-12
(Crawled : 14:30)
- biospace.com/
LIXT
|
$3.5
4.68%
13K
|
Health Technology
|
52.17%
|
O:
-1.3%
H:
2.2%
C:
-5.29%
lb-100
application
ces
netherlands
drug
patent
technology
100
collaboration
cancer
biotech
iot
Lixte Biotechnology’s LB-100 Reported to Convert Immunologically Unresponsive (“Cold”) Tumors to Immunologically Responsive (“Hot”) Tumors
Published:
2022-01-05
(Crawled : 14:00)
- biospace.com/
LIXT
|
$3.5
4.68%
13K
|
Health Technology
|
159.26%
|
O:
122.96%
H:
2.99%
C:
-26.58%
lb-100
technology
100
pons
biotech
iot
response
LIXTE BIOTECHNOLOGY HOLDINGS, INC. ANNOUNCES THAT ENROLLMENT HAS RESUMED IN NATIONAL CANCER INSTITUTE’S TRIAL TO DETERMINE ABILITY OF LIXTE COMPOUND LB-100 TO ENTER RECURRENT, MALIGNANT BRAIN TUMORS
Published:
2021-11-22
(Crawled : 14:30)
- globenewswire.com
LIXT
|
$3.5
4.68%
13K
|
Health Technology
|
103.49%
|
O:
0.0%
H:
3.49%
C:
-3.49%
cancer
biotech
technology
iot
trial
enroll
train
Lixte Biotechnology to Discuss its Collaboration with Leading European Cancer Centers at the Benzinga Global Small Cap Conference on October 28
Published:
2021-10-20
(Crawled : 14:00)
- globenewswire.com
LIXT
|
$3.5
4.68%
13K
|
Health Technology
|
83.25%
|
O:
0.52%
H:
1.56%
C:
-5.73%
europe
collaboration
cancer
biotech
technology
iot
conference
Lixte Biotechnology Announces Collaboration with Netherlands Cancer Institute (Amsterdam) and Oncode Institute (Utrecht) to Identify the Most Promising Drug Combinations for its Lead Clinical Compound, LB-100, for Cancer Treatment
Published:
2021-10-13
(Crawled : 14:00)
- biospace.com/
LIXT
|
$3.5
4.68%
13K
|
Health Technology
|
81.35%
|
O:
3.63%
H:
0.52%
C:
-11.0%
treatment
collaboration
cancer
announces collaboration
biotech
netherlands
drug
technology
iot
Lixte Biotechnology’s LB-100 Shown in Animal Models to Significantly Reduce Behavioral Sensitization, an Important Feature of Methamphetamine Addiction
Published:
2021-08-17
(Crawled : 14:00)
- globenewswire.com
LIXT
|
$3.5
4.68%
13K
|
Health Technology
|
61.29%
|
O:
0.0%
H:
6.91%
C:
2.3%
biotech
technology
iot
LIXTE BIOTECHNOLOGY’S LB-100 ELICITS ANTI- TUMOR ACTIVITY IN SMALL LUNG CANCER MODELS BY UNIQUE MECHANISMS IN AN IMPORTANT PRE-CLINICAL STUDY
Published:
2021-08-03
(Crawled : 14:00)
- globenewswire.com
LIXT
|
$3.5
4.68%
13K
|
Health Technology
|
25.0%
|
O:
18.15%
H:
24.54%
C:
-14.76%
lung cancer
unique
pre-clinical
cancer
biotech
technology
iot
preclinical
LIXTE BIOTECHNOLOGY COMMENTS ON REPORT THAT ITS PP2A INHIBITOR LB-100 COMBINED WITH ANOTHER INVESTIGATIONAL AGENT STIMULATES BONE GROWTH IN MODELS OF DWARFISM
Published:
2021-07-22
(Crawled : 14:00)
- globenewswire.com
LIXT
|
$3.5
4.68%
13K
|
Health Technology
|
24.11%
|
O:
14.89%
H:
0.0%
C:
-12.65%
bone
biotech
growth
technology
iot
Lixte Biotechnology Comments on Outside Research Citing LB-100’s PP2A Inhibition as a Potential Therapeutic Strategy for Triple-Negative Breast Cancer
Published:
2021-07-13
(Crawled : 14:00)
- globenewswire.com
LIXT
|
$3.5
4.68%
13K
|
Health Technology
|
7.69%
|
O:
3.08%
H:
6.56%
C:
-5.07%
potential
cancer
biotech
technology
research
iot
breast cancer
Lixte Biotechnology to Present its Drug Development Pipeline for Cancer Treatment at The MoneyShow Virtual Expo on July 14, 2021
Published:
2021-07-07
(Crawled : 14:00)
- globenewswire.com
LIXT
|
$3.5
4.68%
13K
|
Health Technology
|
18.24%
|
O:
2.7%
H:
4.61%
C:
-1.32%
treatment
cancer
biotech
drug
technology
iot
Lixte Biotechnology and City of Hope Enroll First Patient in Phase 1b Trial of Lead Compound LB-100 for Treatment of Small Cell Lung Cancer
Published:
2021-06-02
(Crawled : 14:00)
- globenewswire.com
LIXT
|
$3.5
4.68%
13K
|
Health Technology
|
23.24%
|
O:
-0.7%
H:
4.61%
C:
-0.35%
treatment
lung cancer
phase 1
cancer
biotech
technology
iot
trial
phase 1b
enroll
phase 2b
LIXTE BIOTECHNOLOGY HOLDINGS, INC. ANNOUNCES THE APPOINTMENT OF REGINA BROWN TO ITS BOARD OF DIRECTORS
Published:
2021-05-12
(Crawled : 14:00)
- globenewswire.com
LIXT
|
$3.5
4.68%
13K
|
Health Technology
|
25.0%
|
O:
-1.07%
H:
1.08%
C:
-2.89%
biotech
technology
iot
Lixte Biotechnology to Discuss Pipeline of Clinical Investigations for Four Cancer Targets at the Benzinga Global Small Cap Conference Being Held May 13-14
Published:
2021-04-28
(Crawled : 14:00)
- globenewswire.com
LIXT
|
$3.5
4.68%
13K
|
Health Technology
|
36.19%
|
O:
1.95%
H:
19.47%
C:
11.45%
cancer
biotech
technology
iot
conference
Lixte Biotechnology Holdings, Inc. Announces the Appointment of Gil N Schwartzberg to its Board of Directors
Published:
2021-04-13
(Crawled : 14:00)
- globenewswire.com
LIXT
|
$3.5
4.68%
13K
|
Health Technology
|
11.82%
|
O:
-0.96%
H:
0.0%
C:
-6.45%
biotech
technology
iot
Gainers vs Losers
56%
44%
Top 10 Gainers
INVO
|
$1.76
131.58%
56.82%
230M
|
Health Technology
SINT
|
$0.0365
59.39%
37.26%
470M
|
Health Technology
WISA
4
|
$9.19
50.66%
33.7%
65M
|
Electronic Technology
EDBL
|
$6.73
47.91%
32.39%
13M
|
GCTK
|
$0.715
36.27%
26.62%
640K
|
Manufacturing
TCON
|
$2.33
36.26%
26.61%
2M
|
Health Technology
TIRX
|
$0.48
6.43%
24.58%
4.8M
|
KZIA
|
$0.38
30.58%
23.42%
300K
|
Health Technology
VNDA
|
$5.23
29.14%
22.56%
24M
|
Health Technology
ATNF
|
$1.91
29.05%
22.51%
310K
|
Your saved searches
Save your searches and get alerts when important news are released.